☰

Chirag B Patel - Publications

Affiliations: 
Stanford University School of Medicine, Palo Alto, CA, United States 
Area:
Neuro-oncology, molecular imaging, tumor treating fields (TTFields)
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Alhusaini S, Naya L, Reddy SA, Patel CB. MEK Pathway Inhibitor-Mediated Response in BRAF V600-Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases. Annals of Neurology. PMID 39324488 DOI: 10.1002/ana.27062  0.652
2024 Nguyen H, Schubert KE, Pohling C, Chang E, Yamamoto V, Zeng Y, Nie Y, Van Buskirk SL, Schulte RW, Patel CB. Impact of glioma peritumoral edema, tumor size, and tumor location on alternating electric fields (AEF) therapy in realistic 3D rat glioma models: a computational study. Physics in Medicine and Biology. PMID 38417178 DOI: 10.1088/1361-6560/ad2e6c  0.783
2024 Wang DH, Fujita Y, Dono A, Rodriguez Armendariz AG, Shah M, Putluri N, Pichardo-Rojas PS, Patel CB, Zhu JJ, Huse JT, Parker Kerrigan BC, Lang FF, Esquenazi Y, Ballester LY. The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathologica Communications. 12: 13. PMID 38243318 DOI: 10.1186/s40478-024-01722-1  0.526
2023 Iv M, Naya L, Sanan S, Van Buskirk SL, Nagpal S, Thomas RP, Recht LD, Patel CB. Tumor treating fields increases blood-brain barrier permeability and relative cerebral blood volume in patients with glioblastoma. The Neuroradiology Journal. 19714009231207083. PMID 37931176 DOI: 10.1177/19714009231207083  0.763
2023 Nguyen H, Schubert KE, Chang E, Nie Y, Pohling C, Van Buskirk SL, Yamamoto V, Zeng Y, Schulte RW, Patel CB. Electric field distributions in realistic 3D rat head models during alternating electric field (AEF) therapy: a computational study. Physics in Medicine and Biology. PMID 37703902 DOI: 10.1088/1361-6560/acf98d  0.766
2022 Wu A, Huang RJ, Colón GR, Zembrzuski C, Patel CB. Low rates of structured advance care planning documentation in electronic health records: results of a single-center observational study. Bmc Palliative Care. 21: 203. PMID 36419072 DOI: 10.1186/s12904-022-01099-9  0.597
2022 Pohling C, Nguyen H, Chang E, Schubert KE, Nie Y, Bashkirov V, Yamamoto V, Zeng Y, Stupp R, Schulte RW, Patel CB. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy. Bioelectrochemistry (Amsterdam, Netherlands). 149: 108287. PMID 36306728 DOI: 10.1016/j.bioelechem.2022.108287  0.789
2022 Ceran Y, Ergüder H, Ladner K, Korenfeld S, Deniz K, Padmanabhan S, Wong P, Baday M, Pengo T, Lou E, Patel CB. TNTdetect.AI: A Deep Learning Model for Automated Detection and Counting of Tunneling Nanotubes in Microscopy Images. Cancers. 14. PMID 36230881 DOI: 10.3390/cancers14194958  0.735
2022 Sahan AZ, Baday M, Patel CB. Biomimetic Hydrogels in the Study of Cancer Mechanobiology: Overview, Biomedical Applications, and Future Perspectives. Gels (Basel, Switzerland). 8. PMID 36005097 DOI: 10.3390/gels8080496  0.753
2022 Arami H, Kananian S, Khalifehzadeh L, Patel CB, Chang E, Tanabe Y, Zeng Y, Madsen SJ, Mandella MJ, Natarajan A, Peterson EE, Sinclair R, Poon ASY, Gambhir SS. Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars. Nature Nanotechnology. PMID 35995855 DOI: 10.1038/s41565-022-01189-y  0.759
2021 Beinat C, Patel CB, Haywood T, Murty S, Naya L, Castillo JB, Reyes ST, Phillips M, Buccino P, Shen B, Park JH, Koran ME, Alam IS, James ML, Holley D, et al. A Clinical PET Imaging Tracer ([F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34475101 DOI: 10.1158/1078-0432.CCR-21-0544  0.768
2021 Wu A, Ruiz Colón G, Aslakson R, Pollom E, Patel CB. Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review. Cancers. 13. PMID 34201260 DOI: 10.3390/cancers13122867  0.608
2021 Aguilar AA, Ho MC, Chang E, Carlson KW, Natarajan A, Marciano T, Bomzon Z, Patel CB. Permeabilizing Cell Membranes with Electric Fields. Cancers. 13. PMID 34068775 DOI: 10.3390/cancers13092283  0.745
2021 Dono A, Mitra S, Shah M, Takayasu T, Zhu JJ, Tandon N, Patel CB, Esquenazi Y, Ballester LY. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. Journal of Neuro-Oncology. PMID 33881725 DOI: 10.1007/s11060-021-03755-1  0.575
2021 Patel C, Beinat C, Xie Y, Chang E, Gambhir S. BIMG-16. TRACKING TTFIELDS-INDUCED ALTERATIONS IN GLIOBLASTOMA METABOLISM WITH [18F]DASA-23, A NON-INVASIVE PROBE OF PYRUVATE KINASE M2 (PKM2) Neuro-Oncology Advances. 3: i4-i4. DOI: 10.1093/noajnl/vdab024.015  0.791
2021 Beinat C, Patel C, Haywood T, Murty S, Naya L, Hayden-Gephart M, Khalighi M, Massoud T, Iagaru A, Davidzon G, Thomas R, Nagpal S, Recht L, Gambhir S. BIMG-13. A NOVEL RADIOPHARMACEUTICAL ([18F]DASA-23) TO MONITOR PYRUVATE KINASE M2 INDUCED GLYCOLYTIC REPROGRAMMING IN GLIOBLASTOMA Neuro-Oncology Advances. 3: i3-i4. DOI: 10.1093/noajnl/vdab024.012  0.786
2020 Patel CB, Beinat C, Xie Y, Chang E, Gambhir SS. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression. Neoplasia (New York, N.Y.). 23: 58-67. PMID 33221711 DOI: 10.1016/j.neo.2020.11.003  0.807
2020 Li D, Patel CB, Xu G, Iagaru A, Zhu Z, Zhang L, Cheng Z. Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging. Frontiers in Immunology. 11: 592389. PMID 33193439 DOI: 10.3389/fimmu.2020.592389  0.45
2020 Murty S, Haile ST, Beinat C, Aalipour A, Alam IS, Murty T, Shaffer TM, Patel CB, Graves EE, Mackall CL, Gambhir SS. Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model. Oncoimmunology. 9: 1757360. PMID 32923113 DOI: 10.1080/2162402X.2020.1757360  0.75
2020 Sun J, Patel CB, Jang T, Merchant M, Chen C, Kazerounian S, Diers AR, Kiebish MA, Vishnudas VK, Gesta S, Sarangarajan R, Narain NR, Nagpal S, Recht L. High levels of ubidecarenone (oxidized CoQ) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells. Scientific Reports. 10: 13899. PMID 32807842 DOI: 10.1038/S41598-020-70969-0  0.586
2020 Beinat C, Patel CB, Haywood T, Shen B, Naya L, Gandhi H, Holley D, Khalighi M, Iagaru A, Davidzon G, Gambhir SS. Human biodistribution and radiation dosimetry of [F]DASA-23, a PET probe targeting pyruvate kinase M2. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31938892 DOI: 10.1007/S00259-020-04687-0  0.719
2019 Beinat C, Gowrishankar G, Shen B, Alam IS, Robinson E, Haywood T, Patel CB, Azevedo EC, Castillo J, Ilovich O, Koglin N, Schmitt-Willich H, Berndt M, Mueller A, Zerna M, et al. The characterization of F-hGTS13 for molecular imaging of xC- transporter activity with positron emission tomography. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31171595 DOI: 10.2967/Jnumed.119.225870  0.781
2019 Haywood T, Beinat C, Gowrishankar G, Patel CB, Alam IS, Murty S, Gambhir SS. Positron emission tomography reporter gene strategy for use in the central nervous system. Proceedings of the National Academy of Sciences of the United States of America. PMID 31123153 DOI: 10.1073/Pnas.1901645116  0.768
2019 Beinat C, Patel CB, Xie Y, Gambhir SS. Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [F]DASA-23. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 30989436 DOI: 10.1007/S11307-019-01353-2  0.744
2019 Aalipour A, Chuang HY, Murty S, D'Souza AL, Park SM, Gulati GS, Patel CB, Beinat C, Simonetta F, Martinić I, Gowrishankar G, Robinson ER, Aalipour E, Zhian Z, Gambhir SS. Engineered immune cells as highly sensitive cancer diagnostics. Nature Biotechnology. PMID 30886438 DOI: 10.1038/S41587-019-0064-8  0.748
2019 Arami H, Patel CB, Madsen SJ, Dickinson PJ, Davis RM, Zeng Y, Sturges BK, Woolard KD, Habte FG, Akin D, Sinclair R, Gambhir SS. Nanomedicine for Spontaneous Brain Tumors: A Companion Clinical Trial. Acs Nano. PMID 30714717 DOI: 10.1021/Acsnano.8B04406  0.737
2018 Chang E, Patel CB, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS. Tumor treating fields increases membrane permeability in glioblastoma cells. Cell Death Discovery. 4: 113. PMID 30534421 DOI: 10.1038/S41420-018-0130-X  0.765
2018 Natarajan A, Patel CB, Ramakrishnan S, Panesar PS, Long SR, Gambhir SS. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1 : Validation in Mouse Models and Human Cancer Tissues. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30373750 DOI: 10.1158/1078-0432.Ccr-18-1871  0.677
2018 Beinat C, Haywood T, Chen YS, Patel CB, Alam IS, Murty S, Gambhir SS. The Utility of [F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29736561 DOI: 10.1007/S11307-018-1194-Y  0.768
2018 Natarajan A, Patel CB, Habte F, Gambhir SS. Dosimetry Prediction for Clinical Translation of 64Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression. Scientific Reports. 8: 633. PMID 29330552 DOI: 10.1038/S41598-017-19123-X  0.673
2017 Chang E, Pohling C, Beygui N, Patel CB, Rosenberg J, Ha DH, Gambhir SS. Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields. Journal of Neuro-Oncology. PMID 28681243 DOI: 10.1007/S11060-017-2534-5  0.794
Show low-probability matches.